AzTrials
AzTrials

Grade III and IV HemorrhoidsNCT07360912

Haemorrhoidectomy With vs Without Lateral Internal Sphincterotomy

A study testing Hemorrhoidectomy With LIS and Conventional Hemorrhoidectomy in people with Grade III and IV Hemorrhoids, run by University of Baghdad at 1 site in Iraq.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Hemorrhoids are a common anorectal condition that often require surgical treatment in advanced stages. Open hemorrhoidectomy is effective but is frequently associated with significant postoperative pain and early bleeding. Read more about this study

Who is it for?
Ages 18 to 70 years
Conditions the study is for
Grade III and IV Hemorrhoids
What is being tested?
Hemorrhoidectomy With LIS and Conventional Hemorrhoidectomy
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
120 participants
Where
1 siteIraq
Study dates
1 Mar 2024to 30 Jul 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adults aged 18 to 70 years
  • Patients diagnosed with grade III or IV hemorrhoids
  • Patients scheduled for open hemorrhoidectomy
  • Patients able to provide informed consent

Who cannot join

  • Patients with inflammatory bowel disease
  • Patients with anal fissure, fistula, or anorectal malignancy
  • Patients with previous anorectal surgery
  • Patients with bleeding or coagulation disorders
  • Patients unfit for surgery or general or spinal anesthesia

Trial locations and contacts

1 site in 1 country.

Iraq1 site
  • University of baghdad collage of medicine

    Baghdad

Other trials in Iraq

About this study

Official title: Open Haemorrhoidectomy Combined With Lateral Internal Sphincterotomy Versus Conventional Haemorrhoidectomy: A Prospective Randomized Comparative Study

Hemorrhoids are a common anorectal condition that often require surgical treatment in advanced stages. Open hemorrhoidectomy is effective but is frequently associated with significant postoperative pain and early bleeding. Increased anal sphincter spasm after surgery is believed to be a major contributor to these complications.

This study evaluates whether adding lateral internal sphincterotomy (LIS) to conventional open hemorrhoidectomy reduces postoperative pain and bleeding. A total of 120 adult patients with Grade III or IV hemorrhoids were randomized to undergo either open hemorrhoidectomy with LIS or open hemorrhoidectomy alone. Postoperative pain was assessed using a visual analogue scale, and postoperative bleeding was recorded at 24 hours, 48 hours, one week, and two weeks after surgery.

The results of this trial aim to determine whether the addition of LIS provides better short-term recovery and improved postoperative outcomes compared with standard hemorrhoidectomy.

Read the detailed description

This was a prospective, randomized, comparative clinical trial conducted at Baghdad Teaching Hospital, Iraq, between March 2024 and July 2025. Adult patients aged 18 to 70 years with symptomatic Grade III or IV hemorrhoids were eligible for inclusion. Patients with other anorectal diseases, previous anorectal surgery, inflammatory bowel disease, malignancy, or significant comorbidities were excluded.

A total of 120 patients were randomly assigned into two groups using sealed opaque envelopes. Group A underwent open hemorrhoidectomy combined with lateral internal sphincterotomy, while Group B underwent open hemorrhoidectomy alone. All procedures were performed under general anesthesia by the same experienced surgeon to maintain procedural consistency.

Postoperative pain was assessed using a visual analogue scale at 24 hours, 48 hours, one week, and two weeks after surgery. Postoperative bleeding was recorded at the same time points. Standard postoperative care, including analgesia and sitz baths, was provided to all patients.

The primary outcome was the proportion of patients who were pain-free at one week after surgery. Secondary outcomes included postoperative bleeding at all follow-up time points. The study aimed to evaluate whether the addition of lateral internal sphincterotomy improves early postoperative recovery compared with conventional hemorrhoidectomy alone.

Being tested
Hemorrhoidectomy With LIS, Conventional Hemorrhoidectomy
Keywords
Hemorrhoids, Hemorrhoidectomy, Lateral Internal Sphincterotomy, Postoperative Pain, Postoperative Bleeding
Medical subject headings
Lymphoma, Follicular, Hemorrhoids, Pain, Postoperative, Postoperative Hemorrhage

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Hemorrhoidectomy With LISProcedure or surgery

    Open excisional hemorrhoidectomy combined with lateral internal sphincterotomy to reduce anal sphincter spasm and postoperative pain.

  • Conventional HemorrhoidectomyProcedure or surgery

    Standard open excisional hemorrhoidectomy without lateral internal sphincterotomy.

Study groups in NCT07360912
Study groupRoleWhat they receive
Hemorrhoidectomy With LISExperimentalPatients undergo open hemorrhoidectomy combined with lateral internal sphincterotomy to reduce postoperative pain and anal sphincter spasm.
Receives: Procedure: Hemorrhoidectomy With LIS
Conventional HemorrhoidectomyActive comparatorPatients undergo standard open hemorrhoidectomy without lateral internal sphincterotomy.
Receives: Procedure: Conventional Hemorrhoidectomy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Postoperative Pain

    Pain intensity after hemorrhoidectomy measured using a Visual Analog Scale (VAS, 0-10).

    Measured: Postoperative day 1, day 2, day 7, and day 14

Secondary outcomes (1)
  1. Postoperative bleeding

    Postoperative bleeding was recorded as the presence or absence of bleeding from the surgical site after hemorrhoidectomy.

    Measured: Postoperative day 1, day 2, day 7, and day 14

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Jan 2026
  2. Study start1 Mar 2024
  3. Primary completion30 Jul 2025
  4. Study completion30 Jul 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
120 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07360912
Sponsor's protocol ID
HLS-RCT-2024
Status last verified
Jan 2026
First submitted
13 Jan 2026
Last updated
22 Jan 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared because the dataset contains confidential clinical information and there is no public data repository for this study.

Publications

  • Alsalaumy AHA. Open haemorrhoidectomy combined with lateral internal sphincterotomy versus conventional haemorrhoidectomy: a prospective randomized comparative study. BMC Surg. 2026 Apr 17;26(1):362. doi: 10.1186/s12893-026-03714-5.

    PubMed 41992176

Questions about this trial

What is this clinical trial studying?

A study testing Hemorrhoidectomy With LIS and Conventional Hemorrhoidectomy in people with Grade III and IV Hemorrhoids, run by University of Baghdad at 1 site in Iraq.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Iraq. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Postoperative Pain (time frame: Postoperative day 1, day 2, day 7, and day 14). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07360912, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jan 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in